Hong Kong
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
736.02 |
Jan. 28, 2025 | USD 0.13 | -0.02% |
|
Hong Kong |
|
2 |
97.48 |
Jan. 28, 2025 | USD 0.37 | 4.31% |
|
Hong Kong |
|
3 |
10.41 |
Jan. 27, 2025 | USD 17.19 | 2.12% |
|
Hong Kong |
|
4 |
4.57 |
Jan. 27, 2025 | USD 1.07 | 3.09% |
|
Hong Kong |
|
5 |
3.31 |
Jan. 27, 2025 | USD 0.80 | 2.57% |
|
Hong Kong |
|
6 |
2.86 |
Jan. 28, 2025 | USD 2.68 | -1.44% |
|
Hong Kong |
|
7 |
2.30 |
Jan. 27, 2025 | USD 0.43 | -0.61% |
|
Hong Kong |
|
8 |
2.29 |
Jan. 27, 2025 | USD 0.44 | 1.16% |
|
Hong Kong |
|
9 |
1.99 |
Jan. 28, 2025 | USD 0.46 | 4.31% |
|
Hong Kong |
|
10 |
1.93 |
Jan. 27, 2025 | USD 0.93 | 2.39% |
|
Hong Kong |
|
11 |
1.92 |
Jan. 27, 2025 | USD 0.27 | 0.46% |
|
Hong Kong |
|
12 |
1.78 |
Jan. 27, 2025 | USD 0.38 | 2.08% |
|
Hong Kong |
|
13 |
1.67 |
Jan. 27, 2025 | USD 0.22 | -1.18% |
|
Hong Kong |
|
14 |
1.45 |
Jan. 27, 2025 | USD 0.41 | 0.30% |
|
Hong Kong |
|
15 |
1.43 |
Jan. 27, 2025 | USD 0.15 | -0.02% |
|
Hong Kong |
|
16 |
1.39 |
Jan. 28, 2025 | USD 1.48 | 0.68% |
|
Hong Kong |
|
17 |
1.22 |
Jan. 27, 2025 | USD 0.52 | 0.23% |
|
Hong Kong |
|
18 |
0.88 |
Jan. 28, 2025 | USD 0.19 | -0.02% |
|
Hong Kong |
|
19 |
0.69 |
Jan. 27, 2025 | USD 0.16 | -3.21% |
|
Hong Kong |
|
20 |
0.48 |
Jan. 28, 2025 | USD 0.25 | -2.07% |
|
Hong Kong |
|
21 |
0.12 |
Jan. 27, 2025 | USD 0.67 | 1.15% |
|
Hong Kong |
The Healthcare company in Hong Kong with the highest Price to Sales Ratio (P/S) is SinoMab BioScience Limited (HKSE: 3681.HK) at 736.02.
The Healthcare company in Hong Kong with the lowest Price to Sales Ratio (P/S) is China Resources Pharmaceutical Group Limited (HKSE: 3320.HK) at 0.12.
The top 10 Healthcare companies in Hong Kong by Price to Sales Ratio (P/S) are SinoMab BioScience Limited, Sirnaomics Ltd., BeiGene, Ltd., Beijing Tong Ren Tang Chinese Medicine Company Limited, Guangdong Hybribio Biotech Co.,Ltd., HUTCHMED (China) Limited, Tycoon Group Holdings Limited, OrbusNeich Medical Group Holdings Limited, Alibaba Health Information Technology Limited and China Medical System Holdings Limited.
The bottom 10 Healthcare companies in Hong Kong by Price to Sales Ratio (P/S) are China Resources Pharmaceutical Group Limited, China Traditional Chinese Medicine Holdings Co. Limited, Lee's Pharmaceutical Holdings Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, Modern Dental Group Limited, The United Laboratories International Holdings Limited, Dawnrays Pharmaceutical (Holdings) Limited, SSY Group Limited, Frontage Holdings Corporation and Sino Biopharmaceutical Limited.